“Real-world Experience with Advanced Long-term Prophylaxis Agents to Treat Hereditary Angioedema in Canada”, Can Allergy Immunol Today, vol. 5, no. s01, pp. 2–9, Mar. 2025, doi: 10.58931/cait.2025.5s0176.